Naylor GJ. Vanadium and manic depressive psychosis.
Nutr Health.
1984;3:79-85.
Reading SA. Chromium picolinate.
J Fla Med Assoc.
1996;83:29-31.
Stoll AL, Locke CA, Marangell LB, et al. Omega-3 fatty acids and bipolar disorder: a review.
Prostaglandins Leukot Essent Fatty Acids.
1999;60:329-337.
Mebane AH. L-Glutamine and mania [letter].
Am J Psychiatry.
1984;141:1302-1303.
Attenburrow MJ, Odontiadis J, Murray BJ, et al. Chromium treatment decreases the sensitivity of 5-HT(2A) receptors.
Psychopharmacology.
2002;159:432-436.
Vazquez I, Aguera-Ortiz LF. Herbal products and serious side effects: a case of ginseng-induced manic episode.
Acta Psychiatr Scand.
2002;105:76-77.
Barbenel DM, Yusufi B, O'Shea D, et al. Mania in a patient receiving testosterone replacement postorchidectomy taking St John's Wort and sertraline.
J Pscyhopharmacol.
2000;14:84-86.
Nierenberg AA, Burt T, Matthews J, et al. Mania associated with St John's Wort.
Biol Psychiatry.
1999;45:1707-1708.
Dolberg OT, Dannon PN, Schreiber S, et al. Transcranial magnetic stimulation in patients with bipolar depression: a double-blind, controlled study.
Bipolar Disord.
2002;4:94-95.
Naylor GJ, Smith AH. Vanadium: a possible aetiological factor in manic depressive illness.
Psychol Med.
1981;11:249-256.
Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long term lithium therapy.
Br J Psychiatry.
1982;141:87-89.
Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long term lithium therapy.
Br J Psychiatry.
1982;141:87-89.
Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis.
J Affect Disord.
1986;10:9-13.
Chengappa KN, Levine J, Gershon S, et al. Inositol as an add-on treatment for bipolar depression.
Bipolar Disord.
2000;2:47-55.
Levine J, Witztum E, Greenberg BD, et al. Inositol induced mania? [letter].
Am J Psychiatry.
1996;153:839.
Carney MW, Chary TK, Bottiglieri T, et al. The switch mechanism and the bipolar/unipolar dichotomy.
Br J Psychiatry.
1989;154:48-51.
Carney MW, Chary TK, Bottiglieri T, et al. Switch and S-adenosylmethionine.
Ala J Med Sci.
1988;25:316-319.
Kagan BL, Sultzer DL, Rosenlicht N, et al. Oral S-adenosylmethionine in depression: a randomized, double-blind placebo-controlled trial.
Am J Psychiatry.
1990;147:591-595.
Frangou S, Lewis M, McCrone P, et al. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
Br J Psychiatry.
2006;188:46-50.
Zhang ZJ, Kang WH, Tan QR, et al. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.
J Psychiatr Res.
2005 Aug 1. [Epub ahead of print].
Allan SJ, Kavanagh GM, Herd RM, et al. The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial.
Br J Dermatol.
2004;150:966-969.
Giannini AJ, Giannini JD, Melemis S, et al. Treatment of acute mania with ambient air anionization: variants of climactic heat stress and serotonin syndrome.
Psychol Rep.
2007;100:157-163.
Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
J Clin Psychiatry.
2007;68:1056-1061.
Keck PE Jr, Mintz J, McElroy SL, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Biol Psychiatry.
2006;60:1020-102. Epub 2006 Jun 30.
Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
J Clin Psychiatry.
2011 Aug 9.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.